Delivery Order SPE2DB25D3201-SPE2DB25FNVSX
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $1,322.94 to AmerisourceBergen Drug Corp for Spiriva Respimat 1.25 mcg inhaler (4 grams) on August 13, 2025, with completion scheduled for August 14, 2025. This firm fixed price delivery order represents a non-competitive set-aside procurement and reflects AmerisourceBergen's role as a critical pharmaceutical supplier within the federal medical supply chain. The product will be delivered to the company's corporate office location in...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 14, 2025, for the supply of Spiriva Respimat 2.5 mcg inhalation medication in 4-gram quantities, with a ceiling value of $1,277.09. This firm fixed-price delivery order, which must be completed by August 15, 2025, represents a competitive award with no set-aside designation. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery...
- The Defense Logistics Agency awarded a $4,865.00 delivery order to AmerisourceBergen Drug Corp on August 4, 2025, for the supply of Spiriva Respimat 2.5 mcg inhalation medication in 4 gram quantities. This firm fixed-price contract, with an ultimate completion date of August 5, 2025, represents a competitively awarded, non-set-aside procurement executed through AmerisourceBergen's existing relationship with DLA. The pharmaceutical product will be delivered to the company's corporate office...
- The Defense Logistics Agency awarded a $1,042.65 delivery order to AmerisourceBergen Drug Corp for Spiriva Respimat 1.25 mcg inhalation medication (4 gm) with an ultimate completion date of August 1, 2025. This competitive award, utilizing firm fixed pricing, was issued with no set-aside designation. The order will be fulfilled from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company maintains its headquarters as a major pharmaceutical distributor...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for SPIRIVA RESPIMAT 1.25 mcg inhalation solution (4 gm) on July 22, 2025, with a ceiling value of $2,903.48. This is a firm fixed-price delivery order with no set-aside designation, representing a competitively awarded procurement. The order is set for completion by July 23, 2025, and will be fulfilled from the vendor's corporate office location in Conshohocken, Pennsylvania. This delivery order is a child...
- The Defense Logistics Agency awarded a delivery order valued at $2,088.20 to AmerisourceBergen Drug Corp for Spiriva Respimat 2.5 micrograms inhaler (4 grams) on August 18, 2025, with an ultimate completion date of August 19, 2025. This competitively awarded, firm fixed-price contract involves no set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. Spiriva Respimat is a prescription maintenance bronchodilator commonly used in...
- The Defense Logistics Agency awarded a delivery order valued at $1,086.40 to AmerisourceBergen Drug Corp for Spiriva Respimat 2.5 mcg inhalation medication (4 grams) on July 29, 2025, with completion scheduled for July 30, 2025. This firm fixed-price, non-set-aside contract is performed at the contractor's facility in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999,999,999.00...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,158.44 to AmerisourceBergen Drug Corp for Spiriva Respimat 1.25 mcg inhalation medication in 4-gram units. This is a firm fixed-price delivery order with no set-aside designation, competitively awarded and due for completion by July 28, 2025. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor and critical vendor for federal medical procurement, particularly serving military...
- The Defense Logistics Agency awarded a delivery order valued at $1,097.88 to AmerisourceBergen Drug Corp for SPIRIVA RESPIMAT 2.5 MCG INH 4GM, a respiratory maintenance medication, with an ultimate completion date of July 30, 2025. The award, issued on July 29, 2025, utilizes firm fixed price pricing and was competitively awarded with no set-aside designation. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving as a critical...
- The Defense Logistics Agency awarded a delivery order valued at $2,982.05 to AmerisourceBergen Drug Corp for SPIRIVA RESPIMAT 2.5 MCG inhalation medication in 4GM quantity. This non-competitive, firm fixed-price delivery order was awarded on May 15, 2025, with an ultimate completion date of May 16, 2025, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The award represents a single delivery order under AmerisourceBergen's larger indefinite delivery contract...
- SPE2DB25D3201Indefinite Delivery Contract
- SPE2DB25D3201-SPE2DB25FNVSXDelivery Order
On August 18, 2025, the Defense Logistics Agency (DLA) awarded a delivery order valued at $1,188.66 to AmerisourceBergen Drug Corp for Spiriva Respimat 2.5 mcg inhalation solution (4 gm). This firm fixed-price contract, with an ultimate completion date of August 19, 2025, is being performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The award was made through open competition with no set-aside designation, reflecting AmerisourceBergen's capability to compete for federal medical procurement requirements. This delivery order is issued under AmerisourceBergen Drug Corp's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a $999.99 billion vehicle running through December 2026 that supports global pharmaceutical supply for military healthcare programs. As a major pharmaceutical distributor, AmerisourceBergen Drug Corp serves the Defense Health Agency, U.S. Coast Guard, and other federal healthcare systems through this comprehensive contract vehicle, which enables the company to supply a broad range of brand-name and generic medications, vaccines, and specialized medical supplies across multiple therapeutic domains to support military personnel and veterans worldwide.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.2k | 8/18/25 |